Clinical trial DS7300-202 - IDeate-Esophageal01
A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd) in Subjects with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
| Organ | Esophagus |
|---|---|
| Trial status | Trial open for recruitment |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Daiichi Sankyo |
| EudraCT Identifier | 2023-509630-19-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT06644781 |
| Last update |